Shannen Doherty Calls Herself a‘#CancerSlayer’ in Breast Cancer Treatment Update
The Beverly Hills 90210 actress was diagnosed with stage IV breast cancer in 2015.
Immunicom Appoints Jennifer Haldeman as Vice President of Commercial Operations
SAN DIEGO–(BUSINESS WIRE)–Mar 1, 2022–
Co Down sisters who beat cancer say breast screening saved both their lives
“Action Cancer saved both our lives.”
Tuesday, March 1, 2022
Tuesday’s California health news roundup covers dropping mask rules, covid infections, vaccines, State of the Union preview, heat and more.
Fewer Breast Cancers May Be ‘Overdiagnosed’ by Mammograms Than Thought
TUESDAY, March 1, 2022 (HealthDay News) — Screening mammograms can lead to overdiagnosis of breast cancer, but a new study finds it happens less often than experts have thought.Researchers estimated that about 15% of breast cancers caught through rout…
Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million
SANTA BARBARA, Calif., March 01, 2022–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its fin…
TOUCH, The Black Breast Cancer Alliance, and Breastcancer.org lead unprecedented When We Tri(al) movement to address breast cancer clinical trial disparities
/PRNewswire/ — TOUCH, The Black Breast Cancer Alliance and Breastcancer.org are bringing together partners from all corners of healthcare to disrupt the…
Infant formula promoted in ‘aggressive’ and ‘misleading’ ways, says new global report
UNICEF and the World Health Organization issued the paper. It shows “that formula milk marketing remains unacceptably pervasive, misleading and aggressive,” says Tedros Adhanom Ghebreyesus of WHO.
First Edition: March 1, 2022
Today’s early morning highlights from the major news organizations.
AbbVie Provides Update Regarding SKYRIZI® (risankizumab-rzaa) for the Treatment of Moderate to Severe Crohn’s Disease in the U.S.
/PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has extended its review period for SKYRIZI®…